NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-08-31
Reading CRWD? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Intact: The reason to own it still holds.
CrowdStrike grows revenue about 26% yearly. Profit losses shrink steadily. The company plans $20 billion ARR. It buys back $1.5 billion in shares.
Revenue growth may slow below 25%. CEO stock sales raise trust issues. Profit losses remain large. Market worries about growth persist.
Analysts expect about 25% revenue growth next year. Our fair value is 28% below the Street median, showing more cautious outlook.
Breaks if: ARR growth stalls or fails to approach $20 billion
Breaks if: operating income worse than -30.6 million USD in FY27 Q1
Breaks if: YoY revenue growth falls below 25% in FY27
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a speculative growth opportunity. The company is focused on achieving significant revenue growth and improving profitability, but recent performance has been mixed, creating uncertainty in the thesis state.
The market currently reflects a justified valuation, with a low expectations gap. However, CRWD trades at a premium compared to its peers, indicating that investors may have high hopes for future growth despite recent challenges.
Management is on track with key priorities, including revenue growth and improving cash flow. However, the company has recently missed earnings expectations, which raises concerns about its ability to maintain momentum in the near term.
The thesis hinges on the performance of sector bellwethers like MSFT, ORCL, and PLTR. If these companies continue to perform well, it could provide a favorable environment for CRWD. Conversely, any negative guidance from these peers could pose risks to CRWD's growth prospects.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports a more favorable outlook. Additionally, the company is on track to achieve $20 billion in annual recurring revenue. There are no new threats impacting the thesis at this time.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Buyback program is canceled or significantly reduced
Over the next 1 to 3 years, CRWD's trajectory will depend on its ability to navigate sector challenges and deliver on its growth targets. Not investment advice.
